Petros Pharmaceuticals (PTPI)

Company Profile

Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.

Company profile

Ticker

PTPI

Exchange

Website

Incorporated

Location

Fiscal year end

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Abbott Laboratories • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Celgene ...

SEC CIK

0001815903

Corporate docs

Articles of Incorporation & Bylaws

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Metuchen Pharmaceuticals LLC • Neurotrope, Inc. • Timm Medical Technologies, Inc. • Pos-T-Vac, LLC ...

IRS number

851410058

PTPI stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

S-8

Registration of securities for employees

22 Dec 22

8-K

Petros Pharmaceuticals Announces Reverse Stock Split

30 Nov 22

8-K

Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update

15 Nov 22

10-Q/A

2022 Q3

Quarterly report (amended)

15 Nov 22

14 Nov 22

Notice of effectiveness

21 Oct 22

POS AM

Prospectus update (post-effective amendment)

14 Oct 22

DEFA14A

Additional proxy soliciting materials

Latest ownership filings

View all

Iroquois Capital Management, LLC

23 Feb 22

Financial summary

Financial statements Chart PTPI financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	11.18 mm	11.18 mm	11.18 mm	11.18 mm	11.18 mm	11.18 mm
Cash burn (monthly)	704.48 k	(no burn)	4.61 mm	2.03 mm	583.83 k	1.63 mm
Cash used (since last report)	2.75 mm	n/a	18.00 mm	7.92 mm	2.28 mm	6.36 mm
Cash remaining	8.43 mm	n/a	-6.82 mm	3.27 mm	8.90 mm	4.82 mm
Runway (months of cash)	12.0	n/a	-1.5	1.6	15.2	3.0

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2022

PTPI institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	20	24	-16.7%
Opened positions	2	3	-33.3%
Closed positions	6	5	+20.0%
Increased positions	5	7	-28.6%
Reduced positions	3	2	+50.0%

13F shares	Current	Prev Q	Change
Total value	26.57 mm	27.31 mm	-2.7%
Total shares	10.23 mm	10.39 mm	-1.5%
Total puts	15.90 k	77.90 k	-79.6%
Total calls	45.65 k	102.55 k	-55.5%
Total put/call ratio	0.3	0.8	-54.1%

Largest owners	Shares	Value	Change
John D Shulman	7.85 mm	$20.33 mm	0.0%
Intracoastal Capital	1.60 mm	$5.33 mm	0.0%
BLK Blackrock	165.10 k	$139.00 k	-13.9%
Vanguard	119.14 k	$100.00 k	+4.7%
Iroquois Capital Management	103.47 k	$345.00 k	0.0%
Susquehanna International	90.52 k	$75.00 k	NEW
Geode Capital Management	75.37 k	$61.00 k	+7.8%
Citadel Advisors	71.41 k	$59.00 k	+3.5%
Virtu Financial	53.59 k	$44.00 k	NEW
STT State Street	45.44 k	$37.00 k	0.0%

Largest transactions	Shares	Bought/sold	Change
Marshall Wace	0.00	-131.20 k	EXIT
Two Sigma Investments	0.00	-104.12 k	EXIT
Susquehanna International	90.52 k	+90.52 k	NEW
Two Sigma Advisers	0.00	-73.80 k	EXIT
Virtu Financial	53.59 k	+53.59 k	NEW
BLK Blackrock	165.10 k	-26.62 k	-13.9%
Veritable	16.87 k	+16.87 k	NEW
Simplex Trading	23.36 k	+13.48 k	+136.3%
Geode Capital Management	75.37 k	+5.45 k	+7.8%
Vanguard	119.14 k	+5.32 k	+4.7%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

PTPI insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	#Shares	#Remaining
20 Jan 23	Bernstein Bruce	Common Stock	Option exercise	Acquire M	No	No	2,264	2,296
20 Jan 23	Bernstein Bruce	RSU Common Stock	Option exercise	Dispose M	No	No	2,264	0
20 Jan 23	Greg Bradley	Common Stock	Option exercise	Acquire M	No	No	2,264	2,264
20 Jan 23	Greg Bradley	RSU Common Stock	Option exercise	Dispose M	No	No	2,264	0
20 Jan 23	Silverman Joshua	Common Stock	Option exercise	Acquire M	No	No	2,515	4,515
20 Jan 23	Silverman Joshua	RSU Common Stock	Option exercise	Dispose M	No	No	2,515	0
20 Jan 23	Wayne Remell Walker	Common Stock	Option exercise	Acquire M	No	No	2,264	2,264
20 Jan 23	Wayne Remell Walker	RSU Common Stock	Option exercise	Dispose M	No	No	2,264	0
7 Apr 22	Bernstein Bruce	RSU Common Stock	Grant	Acquire A	No	No	60,505	60,505